Cerebral Palsy
Conditions
Keywords
Cerebral palsy, GMFM-66, PEDI
Brief summary
This study is designed to assess effectiveness, safety and cost-utility of conventional rehabilitation and traditional Korean medicine conjugated rehabilitation on children with cerebral palsy.
Detailed description
1. Survey 1. An interview survey on baseline * Basic characteristics * Cause of cerebral palsy * Accompanied disorders * Health problems * Operation history * Drug-taking * Rehabilitation treatment * Korean medicine treatment * Health functional food * Medical care cost 2. An interview survey on 26th and 52nd weeks * Accompanied disorders * Health problems 3. A weekly tracking survey * Health problems * Therapeutic change * Medical care cost * Quality of life 2. Assessment for function development on baseline, 26th and 52nd weeks * Gross Motor Function Classification System (GMFCS) * Gross Motor Function Measure-66 (GMFM-66) * Pediatric Evaluation of Disability Inventory (PEDI)
Interventions
acupuncture and herbal drugs
Sponsors
Study design
Eligibility
Inclusion criteria
* Children with cerebral palsy * Age from 6 to 78 months * whose guardian consent to the present study
Exclusion criteria
* who had an orthopedic operation due to cerebral palsy * who has congenital muscular disease, hereditary disease, or progressive central nervous system diseases * who suffers from severe diseases (ie, cancer, severe heart disease, severe infectious disease)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline on PEDI scores at week 26 and 52 | Baseline, Week 26, Week 52 | The PEDI measures abilities in the three functional domains of self-care, mobility and social function with 217 questions. |
| Change from baseline on GMFM-66 scores at week 26 and 52 | Baseline, Week 26, Week 52 | The GMFM-66 includes 66 items identified through Rasch analysis, which, together, best describe gross motor function in children with cerebral palsy of varying abilities. |
Secondary
| Measure | Time frame |
|---|---|
| Change of severity from baseline on accompanied disorders and health problems at week 24 and 52 | Baseline, Week 26, Week 52 |
Other
| Measure | Time frame | Description |
|---|---|---|
| Economy evaluation | Baseline, Week 26, Week 52 | Direct and indirect medical care cost, Labor productivity of family |
| Number of Participants with Serious and Non-Serious Adverse Events | up to 52 weeks | — |
| Change from baseline on height and weight at week 24 and 52 | Baseline, Week 26, Week 52 | — |
Countries
South Korea